**Fundingsources:** None

Conflicts of interest:

Dr Anesi has pending fees from UpToDate for authoring COVID-19 clinical reference material. Research time is supported by AHRQ K12HS026372.

Dr Armstrong has served as a research investigator and/or scientific advisor to Leo, AbbVie, UCB, Janssen, Lilly, Novartis, Ortho Dermatologics, Sun, Dermavant, BMS, Sanofi, Regeneron, Dermira, and Modmed.

Dr Blauvelt has served as a scientific adviser and/or clinical study investigator for AbbVie, Almirall, Arena, Athenex, Boehringer Ingelheim, Bristol-Myers Squibb, Dermavant, Eli Lilly and Company, Forte, Galderma, Incyte, Janssen, Leo, Novartis, Pfizer, Rapt, Regeneron, Sanofi Genzyme, Sun Pharma, and UCB Pharma, and as a paid speaker for AbbVie.

Dr. Bell, Gondo, Heydon, Koons, Smith are employees of the National Psoriasis Foundation

Dr Calabrese is a speaker for Sanofi-Regeneron and consultant for AbbVie

Dr. Feldman received research, speaking and/or consulting support from Galderma, GSK/Stiefel, Almirall, Alvotech, Leo Pharma, BMS, Boehringer Ingelheim, Mylan, Celgene, Pfizer, Ortho Dermatology, Abbvie, Samsung, Janssen, Lilly, Menlo, Merck, Novartis, Regeneron, Sanofi, Novan, Qurient, National Biological Corporation, Caremark, Advance Medical, Sun Pharma, Suncare Research, Informa, UpToDate and National Psoriasis Foundation. Dr Feldman also consults for others through Guidepoint Global, Gerson Lehrman and other consulting organizations. He is the founder and majority owner of www.DrScore.com. He is also a founder and part owner of Causa Research, a company dedicated to enhancing patients' adherence to treatment.

Dr Gelfand served as a consultant for Bristol-Myers Squibb, Boehringer Ingelheim, GlaxoSmithKline, Janssen Biologics, Novartis Corp, Regeneron, UCB (Data Safety and Monitoring Board), and Sanofi and Pfizer Inc, receiving honoraria; in addition, he receives research grants (to the Trustees of the University of Pennsylvania) from Abbvie, Janssen, Novartis Corp, Sanofi, Celgene, OrthoDermatologics, and Pfizer Inc, and he has received payment for CME work related to psoriasis that was supported indirectly by Eli Lilly and Company and Ortho Dermatologics. In addition, Dr Gelfand is a co-patent holder of resiquimod for treatment of cutaneous T-cell lymphoma, and he is a deputy editor for the Journal of Investigative Dermatology, receiving honoraria from the Society for Investigative Dermatology.

Dr Gladman is a consultant for Abbvie, Amgen, BMS, Galapagos, Gilead, Eli Lilly, Janssen, Novartis, Pfizer, UCB. Grants: Abbvie, Amgen, Eli Lilly, Janssen, Novartis, Pfizer, UCB

Dr. Kircik has served either as an investigator, consultant, or speaker for Abbive, Almirall, Amgen, Arcutis, Bausch Health Canada, Bristol-Myers Squibb,Boehringer Ingelheim, Cellceutix, Celgene, Coherus,Dermavant, Dermira, Eli Lilly, Leo, MC2, Maruho , Novartis, Ortho Dermatologics, Pfizer, Dr Reddy\'s, Sun Pharma, UCB, Taro , Xenoport

Dr Lebwohl is an employee of Mount Sinai and receives research funds from: Abbvie, Amgen, Arcutis, Boehringer Ingelheim, Dermavant, Eli Lilly, Incyte, Janssen Research & Development, LLC, Leo Pharmaceutucals, Ortho Dermatologics, Pfizer, and UCB, Inc.and is a consultant for Aditum Bio, Allergan, Almirall, Arcutis, Inc., Avotres Therapeutics, BirchBioMed Inc., BMD skincare, Boehringer-Ingelheim, Bristol-Myers Squibb, Cara Therapeutics, Castle Biosciences, Corrona, Dermavant Sciences, Evelo, Facilitate International Dermatologic Education, Foundation for Research and Education in Dermatology, Inozyme Pharma, Kyowa Kirin, LEO Pharma, Meiji Seika Pharma, Menlo, Mitsubishi, Neuroderm, Pfizer, Promius/Dr. Reddy's Laboratories, Serono, Theravance, and Verrica.

Dr. Martin is a consultant for Almirall, Athenex, Bristol-Meyers Squibb, Celgene, Eli Lilly, LEO, Ortho Dermatologic, Pfizer, UCB and a Scientific Advisor for Almirall, Athenex, Bristol-Meyers Squibb, Celgene, Eli Lilly, Janssen, LEO, Ortho Dermatologic, Pfizer, UCB

Dr Merola is a consultant and/or investigator for Bristol-Myers Squibb, Abbvie, Dermavant, Eli Lilly, Novartis, Janssen, UCB, Sun Pharma, Pfizer, EMD Sorono

Dr Ritchlin reports personal fees from AbbVie, Amgen, Janssen, Novartis, UCB, Boerhinger Ingelheim, as well as grants from Amgen, UCB and Abbvie outside the submitted work

Dr. Schwartzman is a speaker for AbbVie Genentech Janssen Lilly Novartis Pfizer UCB, owns stock in Amgen

Boston scientific Gilead Medtronic Pfizer, is a consultant for AbbVie Myriad Janssen Gilead Lilly Novartis UCB, is a scientific advisory board member for Myriad, and is a Board Member of the National Psoriasis Foundation.

Dr Scher is a consultant for UCB, Janssen, Abbvie, Pfizer, Novastis, Sanofi

Dr Syed is supported by a grant from Pfizer

Dr. Van Voorhees has been an investigator for Celgene, Lilly and AbbVie. She has been an advisor/consultant for the following companies: AbbVIe, Allergan, Astra Zeneca, Celgene, Dermira, Merck, Novartis, Pfizer, UCB, Valeant

Drs. Weinstein, Ellebrecht, Ocon, Fenner, Treat, Dommasch, and Lo Re, have no conflicts of interest to disclose
